MINI FUTURE BULL - IPSEN | Market Closed - Euronext Paris 10:00:01 02/07/2024 pm IST | ||
| 2.07 EUR | -1.90% |
|
| Current month | -10.00% | ||
| 1 month | -9.61% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 02/24/02 | 2.07 | -1.90% |
| 01/24/01 | 2.11 | -8.26% |
| 28/24/28 | 2.3 | +9.52% |
| 27/24/27 | 2.1 | -1.41% |
| 26/24/26 | 2.13 | -1.84% |
Real-time Euronext Paris
Last update July 02, 2024 at 10:00 pm IST
More quotesStatic data
| Product type | Knock-Out con Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
UniCredit
|
| 0929T | |
| ISIN | DE000HC56KJ8 |
| Date issued | 21/03/2023 |
| Strike | 75.02 € |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.05 € |
|---|---|
| Lowest since issue | 1.32 € |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
113.8
EUR
Average target price
127.3
EUR
Spread / Average Target
+11.84%
- Stock Market
- Certificates
- 0929T Certificat
